CommercialCoverageMedium impact
Urinary Test for Renal Allograft Dysfunction
Blue Cross & Blue Shield of Mississippi·MS · Nephrology, Urology, Internal Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi has issued a new medical policy (A.7.03.15) establishing coverage criteria for urinary tests used to diagnose renal allograft dysfunction in kidney transplant patients. This policy defines when noninvasive urine biomarkers are appropriate alternatives to invasive kidney biopsies for monitoring transplant rejection.
Action Required
Immediately: Review policy A.7.03.15 for urinary tests for renal allograft dysfunction to understand new coverage criteria. Billing team should verify coverage requirements before submitting claims for urine biomarker tests in kidney transplant patients. Ensure documentation supports medical necessity criteria outlined in the policy for renal transplant monitoring services.